HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

antoksyd S

consists primarily of baicalin and baicalein; derived from Scutellaria baicalensis

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Pharmaceutical Preparations
- Drug Combinations: 5337
  - antoksyd S: 2
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        antoksyd S: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        antoksyd S: 2

Experts

1.	Ciesielska, Ewa: 2 articles (07/2004 - 09/2002)
2.	Metodiewa, Diana: 2 articles (07/2004 - 09/2002)
3.	Gulanowski, Bogdan: 1 article (07/2004)
4.	Kochman, Agata: 1 article (07/2004)
5.	Szulawska, Agata: 1 article (07/2004)
6.	Wolszczak, Marian: 1 article (07/2004)
7.	Gwardys, Antoni: 1 article (09/2002)

Related Diseases

1.	Leukemia 07/01/2004 - "Antoksyd S (C/E/XXI), is a novel herbal drug derived in Poland from the powdered roots of Scutellaria baicalensis, and the biological activities of its major components (baicalin and baicalein) were compared on the human leukemia cell line HL-60. " 09/01/2002 - "Here we show for the first time that the novel designed drug, Antoksyd S and its polyphenolic flavones (baicalin and baicalein), act as cell proliferation modifiers of mouse leukemia cells (L1210). " 07/01/2004 - "Taken together, it seems reasonable to suggest that Antoksyd S (C/E/XXI) as compared to baicalin and baicalein, or to the cytostatics cisplatin and doxorubicin, might be an especially good candidate for the future development of new therapeutic techniques, alone or in "combination treatment regimens", to enhance leukemia cell killing."
2.	Neoplasms (Cancer) 09/01/2002 - "This work provides the basis for further investigations of Antoksyd S action in vitro and in vivo, since the presented results are indicative of its intracellular metabolic activation, which can only be partially associated with its observed action towards model cancer cells (mouse leukemia L1210)."
3.	Leukemia L1210 09/01/2002 - "This work provides the basis for further investigations of Antoksyd S action in vitro and in vivo, since the presented results are indicative of its intracellular metabolic activation, which can only be partially associated with its observed action towards model cancer cells (mouse leukemia L1210)."

Related Drugs and Biologics

1.	baicalin
2.	baicalein
3.	Cytostatic Agents
4.	Flavones
5.	Doxorubicin (Adriamycin)
6.	Cisplatin (Platino)